glp 1 efficacy comparison Comparing GLP-type therapies for weight loss in those without diabetes. Two glucagon-like peptide-1 receptor agonists (GLP-1 RAs) (#semaglutide and #liraglutide) and one dual agonist (#tirzepatide) have been FDA-approved for #weightloss in adults GLP-1 trends 2025: real-world data,

Evaluation of verapamil efficacy in Peyronies disease comparing with pentoxifylline

Cooley BC, Nevado J, Mellad J, Yang D, St Hilaire C, Negro A, Fang F, Chen G, San H, Walts AD

What are the benefits of taking NAC with Glycine

Bone Density Decline: Clinical trials have shown that one year of semaglutide therapy can reduce hip bone mineral density (BMD) by approximately 2.6% and lumbar spine density by 2.1%

Targeted rescue of a destabilized mutant of p53 by an in silico screened drug

Exosomes from young healthy human plasma promote functional recovery from intracerebral hemorrhage via counteracting ferroptotic injury